News for Oasmia Pharmaceutical AB (publ) (0N4A.L)

Feb 24, 2022 / 09:00AM GMTOperator Ladies and gentlemen, welcome to the Oasmia Pharmaceutical Audiocast Teleconference Q4 2021. (Operator Instructions) Today, I

Jan 19, 2022 / 01:00PM GMTPresentationJan 19, 2022 / 01:00PM GMT =====================Corporate Participants===================== * Francois R. Martelet

Nov 18, 2021 / 09:00AM GMTOperator Please go ahead.Francois R. Martelet - Oasmia Pharmaceutical AB(publ)-CEO Thank you very much, and good morning, everyone. I'

Aug 19, 2021 / 08:00AM GMTOperator Welcome to the Oasmia Pharmaceutical Audiocast Teleconference Q2 2021. With us today, we have CEO, Francois R. Martelet; and

Mar 01, 2021 / 01:00PM GMTFrancois R. Martelet - Oasmia Pharmaceutical AB(publ)-CEO Thank you, and good afternoon, everyone. I'm very pleased to hear that we ha

Sep 09, 2020 / 08:00AM GMTOperator Welcome to the Oasmia Q1 Reports 2020-2021. With us today, we have CEO, Francois Martelet; and CFO, Michael Winklerfelt. (Ope

Read Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Short Interest Update at ETF Daily News

Read Oasmia Pharmaceutical AB (publ) to Issue Dividend of $0.00 (OTCMKTS:OASMY) at ETF Daily News

Aktieägarna i Terranet AB, org.nr 556707-2128, ("Bolaget") kallas härmed till extra bolagsstämma torsdagen den 30 december 2021. Information med...